Central Pontine Myelinolysis and Lithium Toxicity

Annals of Clinical Psychiatry

Volumn 15, Issue 2, 2003, Pages 133-

  Swartz, Conrad M ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ARTICLE; CENTRAL PONTINE MYELINOLYSIS; CONFUSION; DEHYDRATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; HOSPITALIZATION; HUMAN; HYPONATREMIA; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; THIRST; TREMOR;

ANTIMANIC AGENTS; BIPOLAR DISORDER; FLUID THERAPY; HUMANS; LITHIUM COMPOUNDS; MYELINOLYSIS, CENTRAL PONTINE; RISK FACTORS; TIME FACTORS;

EID: 0347132564     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024644511002     Document Type: Article

References (5)

1. Fabisiak DB, Murray GB, Stern TA: Central pontine myelinolysis manifested by temporary blindness: A possible complication of lithium toxicity. Ann Clin Psychiatry 2002; 14:247-251
2. Swartz CM, Dolinar LJ: Encephalopathy associated with rapid decrease of high levels of lithium. Ann Clin Psychiatry 1995; 7:207-209
3. Swartz CM: Commentary on "Encephalopathy associated with rapid decrease of high levels of lithium." Ann Clin Psychiatry 1996; 8:111-112
4. Swartz CM, Jones P: Hyperlithemia correction and persistent delirium. J Clin Pharmacol 1994; 34:865-870
5. Swartz CM: A case for gradual reduction of high lithium levels. Psychosomatics 1994; 35:411-412